Quinupristin/dalfopristin (RP 59500): a new streptogramin antibiotic (Q41142608)

27 September 2017

1 reference

title

Quinupristin/dalfopristin (RP 59500): a new streptogramin antibiotic (English)

1 reference

27 September 2017

C Chant

1

1 reference

27 September 2017

M J Rybak

series ordinal

2

1 reference

27 September 2017

language of work or name

English

0 references

publication date

1 October 1995

1 reference

Annals of Pharmacotherapy

27 September 2017

1 reference

27 September 2017

29

1 reference

27 September 2017

10

1 reference

27 September 2017

1022-1027

1 reference

Antimicrobial activity against Staphylococcus aureus of semisynthetic injectable streptogramins: RP 59500 and related compounds

27 September 2017

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901013

The in-vitro activity of RP 59500 against gram-positive cocci

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901013

The in-vitro activity of new streptogramins, RP 59500, RP 57669 and RP 54476, alone and in combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901013

In-vitro and in-vivo synergic activity and fractional inhibitory concentration (FIC) of the components of a semisynthetic streptogramin, RP 59500

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901013

In vitro activity of RP 59500, a semisynthetic injectable pristinamycin, against staphylococci, streptococci, and enterococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901013

In vitro activity of RP59500, an injectable streptogramin antibiotic, against vancomycin-resistant gram-positive organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901013

In-vitro activity of RP 59500, a new synergic antibacterial agent, against Legionella spp

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901013

Comparative in-vitro activity of RP 59500

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901013

Comparative in-vitro activity of RP 59500 against clinical bacterial isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901013

Comparative in-vitro activity of azithromycin, macrolides (erythromycin, clarithromycin and spiramycin) and streptogramin RP 59500 against oral organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901013

In-vitro activity of streptogramin RP 59500 against staphylococci, including bactericidal kinetic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901013

Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901013

Intrinsic and unusual resistance to macrolide, lincosamide, and streptogramin antibiotics in bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901013

Activity of RP 59500, a new parenteral semisynthetic streptogramin, against staphylococci with various mechanisms of resistance to macrolide-lincosamide-streptogramin antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901013

Post-antibiotic effects of RP 59500 with Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901013

Studies of RP 59500 in vitro and in a rabbit model of aortic valve endocarditis caused by methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901013

Pharmacodynamic interaction between RP 59500 and gram-positive bacteria infecting fibrin clots

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901013

In vivo activities and penetration of the two components of the streptogramin RP 59500 in cardiac vegetations of experimental endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901013

Pharmacodynamics of RP 59500 alone and in combination with vancomycin against Staphylococcus aureus in an in vitro-infected fibrin clot model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901013

10.1177/106002809502901013

21 January 2018

Identifiers

DOI

0 references

1 reference